By Frank Angst Through the first 10 months of 2014, U.S. horse racing appeared on pace to register its fewest positive drug tests for anabolic steroids since the industry moved to outlaw the drugs from racing in 2008-09. But six positives for the anabolic steroid stanozolol from Nov. 19 to Dec. 19 at Laurel Park
By Tom LaMarra Legislation governing equine medication policy is scheduled to be heard Feb. 18 by the Florida Senate Regulated Industries Committee. Introduced by Republican Sen. Jack Latvala, the bill would bring Florida racing in line with the National Uniform Medication Program. The effort by Florida stakeholders to update equine medication regulations began in earnest
By Blood-Horse Staff The Ocala Breeders' Sales Co. will begin implementing guidelines for controlled therapeutic medications at its 2-year-olds in training under-tack shows this spring that follow the uniform medication model rules created by the Association of Racing Commissioners International. Starting with its March 2-year-olds in training sale's under-tack show March 11-13, the Central Florida
By Tom LaMarra The umbrella group for regulators in North America is examining a new approach to out-of-competition testing that would not only target blood-doping and gene-doping, but also help identify horses at risk of catastrophic injury. Out-of-competition testing, on the books in eight states, has different rules depending on the jurisdiction but was enacted
By Tom LaMarra As part of an examination of its equine medication rules, the Ohio State Racing Commission in February will begin hearing from various industry organizations involved in an effort to adopt uniform policies for all jurisdictions. The OSRC said Ed Martin, president of the Association of Racing Commissioners International, and Dr. Dionne Benson,
by Natalie Voss Since its 2001 foundation, the Racing Medication and Testing Consortium has made strides toward its goals of a nationally uniform set of medication rules and rigorous state drug testing lab accreditation. In December, RMTC anticipated the number of states working under its recommended list of therapeutic medication thresholds would increase from four
by T.D. Thornton The concept of an equine biological passport (EBP) is not new. But the tone and urgency of its discussion among veterinary and regulatory authorities changed this week in the wake of the cobalt scandal in Australia, where news reports characterized Racing New South Wales officials as "scrambling" to introduce EBPs as a
By Blood-Horse Staff The Association of Racing Commissioners International and the Association of Official Racing Chemists will jointly hold a major racing industry roundtable and conference on equine welfare and medication policy April 21-23 at the Grand Hyatt Resort in Tampa, Fla. "The ARCI is the only umbrella organization encompassing the totality of horse racing
By Blood-Horse Staff The Association of Racing Commissioners International said Jan. 5 it is taking steps to ensure regulatory agencies have adequate authority to sanction licensees who violate existing federal restrictions limiting the use of illegally compounded medications. An already approved model rules policy would outlaw the possession or use of a drug, substance, or
NEWS RELEASE December 9, 2014 Contact: Hallie Roach Lewis (859) 224-2848 NATIONAL MEDICATION REFORMS MAKE SIGNIFICANT PROGRESS IN 2014 The horse racing industry made significant progress toward the uniform adoption of national medication reforms in 2014, as regulators in multiple jurisdictions adopted model rules developed by the Racing Medication and Testing Consortium (RMTC) and the
SIGN UP TO RECEIVE RMTC COMMUNICATIONS
Quick Links
Sign up to receive RMTC communications:
Sign up to receive RMTC communications:
